P

Inventor

NAKATSURA TETSUYA

JP12 patents
⚠️ This page may combine multiple inventors who share the name “NAKATSURA TETSUYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV YAMAGUCHI

3 patents
US10781249B2Sep 22, 2020

Anti-GPC3 antibody

UNIV YAMAGUCHI2 citations71
US12129291B2Oct 29, 2024

Anti-GPC3 antibody

UNIV YAMAGUCHI0 citations60
US11718663B2Aug 8, 2023

Anti-GPC3 antibody

UNIV YAMAGUCHI0 citations60

ONCOTHERAPY SCIENCE INC

1 patent
US8053556B2Nov 8, 2011

Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same

ONCOTHERAPY SCIENCE INC5 citations71

KUMAMOTO TECH & IND FOUND

1 patent
US7803533B2Sep 28, 2010

Diagnostic agent for malignant melanoma

KUMAMOTO TECH & IND FOUND2 citations59

NAT CANCER CENTER JAPAN

1 patent
US11603519B2Mar 14, 2023

T-cell receptor

NAT CANCER CENTER JAPAN0 citations57

UNIV KUMAMOTO

1 patent
US8017345B2Sep 13, 2011

Diagnostic kit for malignant melanoma

UNIV KUMAMOTO2 citations57

NISHIMURA YASUHARU

1 patent
US8535942B2Sep 17, 2013

Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same

NISHIMURA YASUHARU0 citations49

KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION

1 patent
US9505824B2Nov 29, 2016

Antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation

KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION2 citations45

PHC CORP

1 patent
US12505904B2Dec 23, 2025

Information management apparatus and non-transitory computer-readable recording medium

PHC CORP0 citations44

NAKATSURA TETSUYA

1 patent
US9404925B2Aug 2, 2016

Cancer antigen and use thereof

NAKATSURA TETSUYA1 citations44

NAT CANCER CT

1 patent
US9465030B2Oct 11, 2016

Kit for diagnosing malignant melanoma

NAT CANCER CT0 citations39